FDA’s Hahn Says Covid-19 Therapeutics Pipeline Is Robust

June 30, 2020, 9:10 PM

Stephen Hahn, the head of FDA, says at coronavirus task force briefing that there are more than 144 active trials of therapeutic agents for Covid-19.

  • Hahn says he expects readouts of those trials in late summer or early fall
  • He also says four vaccines have been approved to go into clinical trials, another six are in the pipeline
    • Says FDA won’t cut corners to approve vaccine

To contact the reporters on this story:
Kasia Klimasinska in Washington at kklimasinska@bloomberg.net;
Mario Parker in Washington at mparker22@bloomberg.net

To contact the editors responsible for this story:
Kasia Klimasinska at kklimasinska@bloomberg.net

Caitlin ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.